FDA Regulations and Auditing Practices for Software Suppliers at a Pharmaceutical Manufacturer

If you are not automatically redirected, follow this link:
http://asq.org/qic/display-item/?item=19719

Theisen; Timothy W.; Neill, Colin J.   (2004, ASQ)   The Pennsylvania State University, University Park, PA

A review of 17 quality audit reports performed between 1992 and 2003 by an international pharmaceutical company identifies three time frames of audit maturity based on government regulation enforcement patterns, supplier quality practices, and the customer's changing expectations. Increased government surveillance caused the pharmaceutical company to make greater contractual demands on its suppliers to establish and comply with quality management practices. The maturity eras described are proposed as a new dimension for audit maturity in the pharmaceutical industry.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments